GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
2,365
Funds Holding Change
-5
Funds Holding Growth
-0.2%
Value
$442B
Holding in Top 10
478
Top 10 Change
+12
Top 10 Growth
+3%
Value Growth
+5%
New
93
Increased
1,017
Reduced
1,068
Closed
76
Capital Inflow
$18.2B
Capital Outflow
$19.1B
Net Capital Flow
-$875M
Capital Flow Change
-$2.62B
Calls
$7.89B
Puts
$7.02B
Net Calls
+$873M
Put/Call Ratio
0.89